BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Big Cap Pro

1 year 30%, 2 years 40% and *3 years 50%

*Across 3 years $2276.64 only $1138.32

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,038.59
0.66%
US Tech 100
20,509.00
0.59%
Dow Jones
44,768.45
-0.32%
Brent Oil
72.005
-0.10%
Bitcoin
96,357.12
-0.93%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG

  6. Uniqure NV (UQ1) Quote

Uniqure NV

Uniqure NV (UQ1)

TG
7.16
1.51
( 26.68% )
Updated: 09:59:33
Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
7.16
Bid
6.794
Ask
6.878
Volume
172
5.71 Day's Range 7.16
3.548 52 Week Range 9.99
Previous Close
5.652
Open
5.71
Last Trade
170
@
7.16
Last Trade Time
09:45:03
Average Volume (3m)
646
Financial Volume
-
VWAP
-

Ask ADVFN Intelligence (AI)

UQ1 Latest News

More News

uniQure Announces Dosing of First Patient in GenTLE Phase I/IIa Clinical Trial of AMT-260 for the Treatment of Refractory Mesial Temporal Lobe Epilepsy

uniQure Announces Dosing of First Patient in GenTLE Phase I/IIa Clinical Trial of AMT-260 for the Treatment of Refractory Mesial Temporal Lobe Epilepsy LEXINGTON, Mass. and AMSTERDAM, Nov. 21...

November 21 2024
UK Regulatory

uniQure Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress

uniQure Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress ~ Type B meeting scheduled with the FDA in the fourth quarter of 2024 to initiate discussions...

November 05 2024
UK Regulatory

uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment SOD1-ALS

uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment SOD1-ALS LEXINGTON, Mass. and AMSTERDAM, Oct. 15, 2024 (GLOBE NEWSWIRE) -- uniQure N.V...

October 15 2024
UK Regulatory

uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease

uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease LEXINGTON, Mass. and AMSTERDAM, Sept. 23, 2024 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a...

September 23 2024
UK Regulatory

uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease

uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease LEXINGTON, Mass. and AMSTERDAM, Aug. 15, 2024 (GLOBE NEWSWIRE) -- uniQure...

August 15 2024
UK Regulatory

uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update

uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update ~ Announced RMAT designation for AMT-130 in Huntington’s disease and positive interim Phase I/II data...

August 01 2024
UK Regulatory

uniQure Announces Closing of Sale of Manufacturing Facility to Genezen

uniQure Announces Closing of Sale of Manufacturing Facility to Genezen ~ uniQure maintains preferential access to industry-leading manufacturing capabilities to support its pipeline of gene...

July 23 2024
UK Regulatory

uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease

uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease ~ Achieved statistically significant...

July 09 2024
UK Regulatory

uniQure Announces Sale of Commercial Manufacturing Facility to Genezen

uniQure Announces Sale of Commercial Manufacturing Facility to Genezen ~ Proposed divestiture streamlines uniQure’s focus and represents an important milestone in its ongoing effort to...

July 01 2024
GlobeNewswire Inc.

uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease

uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease ~ Designation based on 24-month interim Phase...

June 03 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.54427.49287749295.6167.165.6161935.81479876DE
41.9236.6412213745.247.4065.244766.23197376DE
122.17943.74623569564.9817.4064.116465.4987265DE
262.51954.27709545364.6419.993.54812686.96511351DE
520.527.83132530126.649.993.54812246.30769671DE
156-16.89-70.228690228724.0525.833.5486857.10292713DE
260-24.3-77.240940877331.4632.783.5484858.65661687DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
2WOWide Open Agriculture Ltd
0.011 €
(83.33%)
794
7KOCullinan Metals Corp
0.0136 €
(54.55%)
6.02k
27N0Cannovum Cannabis AG
0.406 €
(35.33%)
9.31k
038NovoCure Ltd
25.34 €
(33.83%)
10.01k
FWR0Yumy Candy Company Inc the
0.0488 €
(31.89%)
7.52k
KEHChinese People Holdings Co Ltd
0.001 €
(-66.67%)
5.84k
0PV2Moovly Media Inc
0.0025 €
(-58.33%)
6.59k
CNWCodon AG
0.005 €
(-54.55%)
260
NL8Genesis Ai Corp
0.0056 €
(-53.33%)
450
3RITurmalina Metals Corp
0.0154 €
(-43.38%)
24.85k
POQ88 Energy Limited
0.0013 €
(8.33%)
6.01M
PF8European Lithium Limited
0.0312 €
(13.87%)
4.17M
D7GNel ASA
0.2521 €
(-1.60%)
3.13M
AXIAtos SE
0.7294 €
(-9.95%)
2.44M
VJFVital Metals Ltd
0.0013 €
(-35.00%)
2.12M

Discussion

View Full Feed
02opida 02opida 2 minutes ago
Monday Morning ~ Coffee ~ Tea Everyone
JettaR JettaR 2 minutes ago
Nothing on news page since September. Tells us what? 
RGLG
PEACHMAN PEACHMAN 2 minutes ago
Impact Fusion International Expands Marketing for Supreme AG™
Scientific Testing / Supreme AG™

a. Where SGP+™ utilizes sugarcane bagasse as an ingredient, Supreme AG™
is NOT unrefined bagasse.
b. Processed with native minerals and other naturally occurring substan
IFUS
tedpeele tedpeele 2 minutes ago
finally a chance to move to a new level.
RDAR
Iggy_Bot Iggy_Bot 2 minutes ago
Im surprised this morning the repubs didn't file for impeachment
Golden Cross Golden Cross 2 minutes ago
$ILLR News ⬇️⬇️⬇️
https://trillercorp.com/creator-centric-triller-sean-kims-strategy-for-social-platform-success/
ILLR
jay_tee jay_tee 2 minutes ago
The sad thing is Seamus has stated in his yearly letter to shareholders for ten years that he will bring value to us. I've learned the hard way to take that statement with a grain of salt. Maybe if I toss that salt over my shoulder??? Hmmmm... that might actually work....
RNVA
FACT-MASTER FACT-MASTER 2 minutes ago
SIZZZZl'ing

ASK gett'in annihilated!
ESPR
Idiot Mayor Idiot Mayor 2 minutes ago
Dead cat bounce coming?
ACHR
02opida 02opida 3 minutes ago
Good Post BDEZ
gp22 gp22 3 minutes ago
$MTEK @ $2.20s: Last AI Drone play to rip on volume. A sitting duck right now. Float 4.3M
MTEK
Monroe1 Monroe1 3 minutes ago
Could be a visit to the optometrist is in order.
NBRI
m0n m0n 3 minutes ago
Wishful thinking & Hypotehtical nonsense.

No One is Fooled 
IFUS
Krombacher Krombacher 3 minutes ago
SSC, your recent posts continue to misrepresent facts and recycle unfounded claims. Let's address your points systematically:

1. "Any Day Now" Predictions:
You mock the phrase "any day now," referencing a past sticky post about a deal with Total. While the timeline was longer t
ERHE
gp22 gp22 3 minutes ago
$MTEK @ $2.20s: Last AI Drone play to rip on volume. A sitting duck right now. Float 4.3M
MTEK
Carjockey2 Carjockey2 4 minutes ago
Wowza!!!@@
konshe konshe 4 minutes ago
When we get PPS at 0.30?
ASII
Twilson Twilson 4 minutes ago
You going short on WMT?
WMT
georgie18 georgie18 4 minutes ago
XPON...$2.39...🥳...

georgie18

Member Level
Re: georgie18 post# 254

Tuesday, November 26, 2024 11:37:30 AM

Post#
255
of 256
XPON...$2.30...Small floater...Looking for a bottom Squeeze here...🥳..
XPON
gp22 gp22 4 minutes ago
$MTEK @ $2.20s: Last AI Drone play to rip on volume. A sitting duck right now. Float 4.3M
MTEK
firebag1 firebag1 4 minutes ago
2 fitty!
RDAR
georgie18 georgie18 4 minutes ago
XPON...$2.39...🥳...

georgie18

Member Level
Re: georgie18 post# 254

Tuesday, November 26, 2024 11:37:30 AM

Post#
255
of 256
XPON...$2.30...Small floater...Looking for a bottom Squeeze here...🥳..
XPON
learningcurve2020 learningcurve2020 4 minutes ago
She conned MHRA style="font-size: 1em" into what, allowing her to submit an application?  JAMA simply reported on the Plll outcome with no recommendation. The integrity of the data relies on Bosch.  Countless MD's? BP partners? You're hallucinating again.  
NWBO
IAmTopG IAmTopG 4 minutes ago
Everytime I have hopes that it would keep going up, someone crashed this back down. Thought this would break $3 smh
GMGI

Your Recent History

TG
UQ1
Uniqure NV
USOTC
RLYGF
Riley Gold (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Big Cap Pro

1 year 30%, 2 years 40% and *3 years 50%

*Across 3 years $2276.64 only $1138.32